RAAS inhibitors commonly used in the pharmacological management of hypertension may result in increased expression of angiotensin-converting enzyme 2 (ACE2) [9, 10], which is employed by Coronaviruses for cell infection [12], thereby mediating the susceptibility of cells to SARS-CoV and SARS-CoV-2 infections [12, 18]. Here, ACE2 is linked to infection.